The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Protein-Targeted Gadolinium-Based Magnetic Resonance Imaging (MRI) Contrast Agents: Design and Mechanism of Action
Abstract
Magnetic resonance imaging (MRI) is a powerful medical diagnostic technique: it can penetrate deep into tissue, provide excellent soft tissue contrast with sub-millimeter resolution, and does not employ ionizing radiation. Targeted contrast agents provide an additional layer of molecular specificity to the wealth of anatomical and functional information already attainable by MRI. However, the major challenge for molecular MR imaging is sensitivity: micromolar concentrations of Gd(III) are required to cause a detectable signal change, which makes detecting proteins by MRI a challenge. Protein-targeted MRI contrast agents are bifunctional molecules comprising a protein-targeting moiety and typically one or more gadolinium chelates for detection by MRI. The ability of the contrast agent to enhance the MR image is termed relaxivity, and it depends upon many molecular factors, including protein binding itself. As in other imaging modalities, protein binding provides the pharmacokinetic effect of concentrating the agent at the region of interest. Unique to MRI, protein binding provides the pharmacodynamic effect of increasing the relaxivity of the contrast agent, thereby increasing the MR signal. In designing new agents, optimization of both the targeting function and the relaxivity is critical. In this Account, we focus on optimization of the relaxivity of targeted agents. Relaxivity depends upon speciation, chemical structure, and dynamic processes, such as water exchange kinetics and rotational tumbling rates. We describe mechanistic studies that relate these factors to the observed relaxivities and use these findings as the basis of rational design of improved agents. In addition to traditional biochemical methods to characterize ligand-protein interactions, the presence of the metal ion enables more obscure biophysical techniques, such as relaxometry and electron nuclear double resonance, to be used to elucidate the mechanism of relaxivity differences. As a case study, we explore the mechanism of action of the serum-albumin-targeted angiography agent MS-325 and closely related compounds and show how small changes in the metal chelate can impact relaxivity. We found that, while protein binding generally improves relaxivity by slowing the tumbling rate of the complex, in some cases, the protein itself can also negatively affect hydration of the metal complex and/or inner-sphere water exchange. Drawing on these findings, we designed next-generation agents targeting albumin, fibrin, or collagen and incorporating up to four gadolinium chelates. Through judicious molecular design, we show that high-relaxivity complexes with high target affinity can be realized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
Caravan, P., Ellison, J. J., McMurry, T. J., & Lauffer, R. B. (1999) · Chemical Reviews · doi:10.1021/cr980440x · Cited by 4,483
Self-citationRelaxation Processes in a System of Two Spins
Solomon, I. (1955) · Physical Review · doi:10.1103/physrev.99.559 · Cited by 3,278
All About Albumin: Biochemistry, Genetics, and Medical Applications
Peters, T. (1995) · Thammasat University Digital Collections · Cited by 3,090
Horrocks, W. D., & Sudnick, D. R. (1979) · Journal of the American Chemical Society · doi:10.1021/ja00496a010 · Cited by 1,413
Proton Relaxation Times in Paramagnetic Solutions. Effects of Electron Spin Relaxation
Bloembergen, N., & Morgan, L. O. (1961) · The Journal of Chemical Physics · doi:10.1063/1.1731684 · Cited by 1,348
Water exchange on metal ions: experiments and simulations
Helm, L., & Merbach, A. E. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(99)90232-1 · Cited by 531
MS-325: albumin-targeted contrast agent for MR angiography.
Lauffer, R. B., Parmelee, D. J., Dunham, S. U., Ouellet, H. S., Dolan, R. P., Witte, S., McMurry, T. J., & Walovitch, R. C. (1998) · Radiology · doi:10.1148/radiology.207.2.9577506 · Cited by 457
Anderegg, G., Arnaud-Neu, F., Delgado, R., Felcman, J., & Popov, K. (2005) · Pure and Applied Chemistry · doi:10.1351/pac200577081445 · Cited by 314
Collagen‐Targeted MRI Contrast Agent for Molecular Imaging of Fibrosis
Caravan, P., Das, B., Dumas, S., Epstein, F. H., Helm, P. A., Jacques, V., Koerner, S., Kolodziej, A., Shen, L., Sun, W., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700700 · Cited by 268
Self-citationEP-2104R: A Fibrin-Specific Gadolinium-Based MRI Contrast Agent for Detection of Thrombus
Overoye-Chan, K., Koerner, S., Looby, R. J., Kolodziej, A. F., Zech, S. G., Deng, Q., Chasse, J. M., McMurry, T. J., & Caravan, P. (2008) · Journal of the American Chemical Society · doi:10.1021/ja800834y · Cited by 226
Self-citationHelm, P. A., Caravan, P., French, B. A., Jacques, V., Shen, L., Xu, Y., Beyers, R. J., Roy, R. J., Kramer, C. M., & Epstein, F. H. (2008) · Radiology · doi:10.1148/radiol.2473070975 · Cited by 182
Self-citationIdée, J.-M., Port, M., Medina, C., Lancelot, E., Fayoux, E., Ballet, S., & Corot, C. (2008) · Toxicology · doi:10.1016/j.tox.2008.03.012 · Cited by 161
Caravan, P. D., Parigi, G., Chasse, J. M., Cloutier, N. J., Ellison, J. J., Lauffer, R. B., Luchinat, C., McDermid, S. A., Spiller, M., & McMurry, T. J. (2007) · Inorganic Chemistry · doi:10.1021/ic700686k · Cited by 154
Self-citationCossy, C., Helm, L., Powell, D. H., & Merbach, A. E. (1995) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 118
Multilocus Binding Increases the Relaxivity of Protein‐Bound MRI Contrast Agents
Zhang, Z., Greenfield, M. T., Spiller, M., McMurry, T. J., Lauffer, R. B., & Caravan, P. D. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200502245 · Cited by 114
Self-citationEldredge-Hindy, H., Spiller, M., Chasse, J. M., et al. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000199293.86956.48 · Cited by 85
How Does Internal Motion Influence the Relaxation of the Water Protons in LnIIIDOTA-like Complexes?
Dunand, F. A., Borel, A., & Merbach, A. E. (2002) · Journal of the American Chemical Society · doi:10.1021/ja016873q · Cited by 78
Monovalent and Bivalent Fibrin‐specific MRI Contrast Agents for Detection of Thrombus
Nair, S. A., Kolodziej, A. F., Bhole, G., Greenfield, M. T., McMurry, T. J., & Caravan, P. D. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800563 · Cited by 55
Self-citationA High Relaxivity Magnetic Resonance Imaging Contrast Agent Targeted to Serum Albumin
Dumas, S., Troughton, J. S., Cloutier, N. J., Chasse, J. M., McMurry, T. J., & Caravan, P. D. (2008) · Australian Journal of Chemistry · doi:10.1071/ch08164 · Cited by 12
Self-citation
Cited by
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
Wahsner, J., Gale, E. M., Rodríguez-Rodríguez, A., & Caravan, P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00363 · Cited by 1,603
Self-citationLanthanide Probes for Bioresponsive Imaging
Heffern, M. C., Matosziuk, L. M., & Meade, T. J. (2014) · Chemical Reviews · doi:10.1021/cr400477t · Cited by 1,202
Impact of albumin on drug delivery — New applications on the horizon
Elsadek, B., & Kratz, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.069 · Cited by 832
Size-Tunable, Ultrasmall NaGdF4 Nanoparticles: Insights into Their T1 MRI Contrast Enhancement
Johnson, N. J. J., Oakden, W., Stanisz, G. J., Scott Prosser, R., & van Veggel, F. C. J. M. (2011) · Chemistry of Materials · doi:10.1021/cm201297x · Cited by 414
The pyridyl group in ligand design for selective metal ion complexation and sensing
Hancock, R. D. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35224a · Cited by 353
Metadata
- Authors
- Caravan, P.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-02-17
- Volume
- 42
- Issue
- 7
- Pages
- 851-862
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W2097085758
- Cited by
- 383
- References
- 19
- FWCI
- 18.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.